Baseline prevalence of lung cancer screening and covariates among women undergoing breast cancer screening in Missouri.
Abstract
e22562 Background: We sought to evaluate lung cancer screening (LCS) uptake and determine factors associated with LCS among women participating in a highly-attended breast cancer screening (BCS) program in Missouri. Methods: We conducted a retrospective cohort study using electronic health record data (2019 to 2025) of women aged 50–80 years with documented smoking history undergoing BCS at Barnes-Jewish West County (BJWCH), serving ~4,500 women, and Christian Hospital (CH), serving ~9,000 women in Missouri. LCS eligibility was assessed based on current smoking status, > 20 smoking pack-years, and/or < 15 years since quitting among former smokers. We evaluated LCS uptake and conducted multivariable analyses to explore demographic, behavioral, and area-level characteristics associated with LCS eligibility and uptake. Results: A total of 8,709 women had ever smoked; 2,530 from BJWCH and 6,179 from CH. Most women were non-Hispanic Black (52.4%) and non-Hispanic White (45.2%), with CH serving mostly Blacks (67.6%) and BJWCH primarily White (80.6%). At BJWCH, 30% of women, and at CH, 34.6% had undergone LCS. Only 37% of patients had documented pack-years. Documentation of pack-years was more likely among current smokers (AOR = 1.89; 95% CI: 1.69–2.11; p < 0.001) and was associated with higher likelihood of LCS (AOR = 3.27; 95% CI: 2.97–3.60; p < 0.0001). LCS uptake among those with documented pack-years was 43.8% (N = 411) and 54.6% (N = 1,251) at BJWCH and CH, respectively. Current smoking status was associated with higher LCS uptake (AOR = 2.05, 95% CI: 1.82–2.31, p < 0.001) compared to former smoking status. A dose–response relationship was observed with pack-years and LCS (table 1). Residence in higher neighborhood deprivation was associated with a higher likelihood of LCS (table 1). Effect modification by race/ ethnicity attenuated the positive association between smoking > 40 pack-years and LCS among non-Hispanic Blacks (AOR = 2.03 (95% CI: 1.02–4.03), p = 0.036). Conclusions: LCS uptake among women remains low, and poor documentation of pack-years undermines accurate LCS eligibility determination. LCS uptake was lower among those with former smoking status, and the attenuated association between high pack-years and LCS among non-Hispanic Blacks suggests potential disparities in translating risk to LCS. System-level efforts to strengthen pack-year documentation and LCS-eligibility assessment, particularly among former smokers, could expand uptake of LCS. Variable Reference group AOR 95% CI p-value Pack-year documentation Documented vs not 3.27 2.97–3.60 <0.0001 Smoking status Current vs former 2.05 1.82–2.31 <0.001 Pack-years 20–29 pack years 30–39 1.7 1.27–2.28 <0.001 ≥40 2.79 2.11–3.68 <0.001 Undocumented 0.19 0.16–0.23 <0.001 Area deprivation Category 1 Category 2 1.12 0.87 – 1.45 0.371 Category 3 1.33 1.04–1.69 0.023 Category 4 1.59 1.26–2.00 <0.001
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (9)
Beryne Odeny
Washington University in St. Louis, School of Medicine, St. Louis, MO
Sri Gopalsamy Ramaswamy
School of Public Health at Washington University in St. Louis, Saint Louis, MO
Aren Mnatzakanian
University College Dublin, Dublin, Ireland
Akila Anandarajah
Washington University School of Medicine, St. Louis, MO
Eyerusalem Zewde
School of Public Health at Washington University in St. Louis, St. Louis, MO
Busayo Akinloye
Division Of Public Health Sciences, Washington University In St. Louis School of Medicine, St. Louis, MO
Benjamin Bowe
Washington University School of Medicine, St. Louis, MO
Thomas A. Odeny
Washington University in St. Louis, St. Louis, MO
Michelle V. Lee
Washington University in St. Louis, School of Medicine, St. Louis, MO